Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 7,804 shares at $647.50 ($5.1M) on 2020-07-21, disclosed to the SEC on 2020-07-22.
Open-market sale of $5.1M REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $655.57 | 2,802 | $1.8M | 35.9% |
| 2 | $655.57 | 4,611 | $3.0M | 59.1% |
| 3 | $647.50 | 388 | $251K | 4.9% |
| 4 | $658.00 | 3 | $2K | 0.0% |
| Total | $655.17 avg | 7,804 | $5.1M | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |